Search results
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 7 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 7 days agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day...
Benzinga· 7 days agoShares of AMMO, Inc. POWW fell sharply during Friday's session following fourth-quarter results....
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 4 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
Cramer's Lightning Round: 'Let's stay away' from Unity Software
CNBC· 7 days ago"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 6 days agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and Drug Administration (FDA) announced ...